Jessica K. Peters

Jessica K. Peters

Auto-generated profile, based on publicly available information

Jessica K. Peters

Department of Pharmaceutical Chemistry, University of California, San Francisco, San Francisco, CA 94158, USA

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
4 December 2020 in Science
Verified
Journal Article
Open access
PDF file
DGDavid E. Gordon
David E. Gordon
JHJoseph Hiatt
Joseph Hiatt
MBMehdi Bouhaddou
Mehdi Bouhaddou
VRVeronica V. Rezelj
Veronica V. Rezelj
SUSvenja Ulferts
Svenja Ulferts
HLHarris A. Lewin
Harris A. Lewin
How lethal coronaviruses engage hosts: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is closely related to the deadly coronaviruses SARS-CoV-1 and Middle East respiratory syndrome coronavirus (MERS-CoV). Considerable efforts are focused on developing treatments, and therapies that work across coronaviruses would be particularly valuable. Shedding light on the host factors hijacked by the viruses, Gordon et al. mapped the interactions between viral and human proteins for SARS-CoV-2, SARS-CoV-1, and MERS-CoV; analyzed the localization of viral proteins in human cells; and used genetic screening to identify host factors that either enhance or inhibit viral infection. For a subset of the interactions essential for the virus life cycle, the authors determined the cryo–electron microscopy structures and mined patient data to understand how targeting host factors may be relevant to clinical outcomes. Science , this issue p. eabe9403

16 April 2021 in Science Advances
Verified
Journal Article
Open access
PDF file
MSMarion Schuller
Marion Schuller
GCGalen J. Correy
Galen J. Correy
SGStefan Gahbauer
Stefan Gahbauer
DFDaren Fearon
Daren Fearon
TWTaiasean Wu
Taiasean Wu
IAIvan Ahel
Ivan Ahel
Massive fragment screening effort provides a foundation for the development of macrodomain inhibitors as novel antiviral agents.

24 September 2014 in Nature
Verified
Journal Article
Open access
PDF file
ARAaron R. Robart
Aaron R. Robart
RCRussell T. Chan
Russell T. Chan
JPJessica K. Peters
Jessica K. Peters
KRKanagalaghatta R. Rajashankar
Kanagalaghatta R. Rajashankar
NTNavtej Toor
Navtej Toor
The formation of branched lariat RNA is an evolutionarily conserved feature of splicing reactions for both group II and spliceosomal introns. The lariat is important for the fidelity of 5′ splice-site selection and consists of a 2′-5′ phosphodiester bond between a bulged adenosine and the 5′ end of the intron. To gain insight into this ubiquitous intramolecular linkage, we determined the crystal structure of a eukaryotic group IIB intron in the lariat form at 3.7 Å. This revealed that two tandem tetraloop-receptor interactions, η–η′ and π–π′, place domain VI in the core to position the lariat bond in the post-catalytic state. On the basis of structural and biochemical data, we propose that π–π′ is a dynamic interaction that mediates the transition between the two steps of splicing, with η–η′ serving an ancillary role. The structure also reveals a four-magnesium-ion cluster involved in both catalysis and positioning of the 5′ end. Given the evolutionary relationship between group II and nuclear introns, it is likely that this active site configuration exists in the spliceosome as well.

12 May 2021 in bioRxiv
Verified
Preprint
Open access
PDF file
MGMeghna Gupta
Meghna Gupta
CACaleigh M. Azumaya
Caleigh M. Azumaya
MMMichelle Moritz
Michelle Moritz
SPSergei Pourmal
Sergei Pourmal
ADAmy Diallo
Amy Diallo
KVKliment A Verba
Kliment A Verba
The SARS-CoV-2 protein Nsp2 has been implicated in a wide range of viral processes, but its exact functions, and the structural basis of those functions, remain unknown. Here, we report an atomic model for full-length Nsp2 obtained by combining cryo-electron microscopy with deep learning-based structure prediction from AlphaFold2. The resulting structure reveals a highly-conserved zinc ion-binding site, suggesting a role for Nsp2 in RNA binding. Mapping emerging mutations from variants of SARS-CoV-2 on the resulting structure shows potential host-Nsp2 interaction regions. Using structural analysis together with affinity tagged purification mass spectrometry experiments, we identify Nsp2 mutants that are unable to interact with the actin-nucleation-promoting WASH protein complex or with GIGYF2, an inhibitor of translation initiation and modulator of ribosome-associated quality control. Our work suggests a potential role of Nsp2 in linking viral transcription within the viral replication-transcription complexes (RTC) to the translation initiation of the viral message. Collectively, the structure reported here, combined with mutant interaction mapping, provides a foundation for functional studies of this evolutionary conserved coronavirus protein and may assist future drug design.

25 January 2013 in Nucleic Acids Research
Verified
Journal Article
Open access
PDF file
CHChiaolong Hsiao
Chiaolong Hsiao
TLTimothy K. Lenz
Timothy K. Lenz
JPJessica K. Peters
Jessica K. Peters
PFPo-Yu Fang
Po-Yu Fang
DSDana M. Schneider
Dana M. Schneider
LWLoren Williams
Loren Williams
Ancient components of the ribosome, inferred from a consensus of previous work, were constructed in silico , in vitro and in vivo . The resulting model of the ancestral ribosome presented here incorporates ∼20% of the extant 23S rRNA and fragments of five ribosomal proteins. We test hypotheses that ancestral rRNA can: (i) assume canonical 23S rRNA-like secondary structure, (ii) assume canonical tertiary structure and (iii) form native complexes with ribosomal protein fragments. Footprinting experiments support formation of predicted secondary and tertiary structure. Gel shift, spectroscopic and yeast three-hybrid assays show specific interactions between ancestral rRNA and ribosomal protein fragments, independent of other, more recent, components of the ribosome. This robustness suggests that the catalytic core of the ribosome is an ancient construct that has survived billions of years of evolution without major changes in structure. Collectively, the data here support a model in which ancestors of the large and small subunits originated and evolved independently of each other, with autonomous functionalities.

8 November 2018 in Nature Communications
Verified
Journal Article
Open access
PDF file
RCRussell T. Chan
Russell T. Chan
JPJessica K. Peters
Jessica K. Peters
ARAaron R. Robart
Aaron R. Robart
TWTimothy Wiryaman
Timothy Wiryaman
KRKanagalaghatta R. Rajashankar
Kanagalaghatta R. Rajashankar
NTNavtej Toor
Navtej Toor
The group II intron and the spliceosome share a common active site architecture and are thought to be evolutionarily related. Here we report the 3.7 Å crystal structure of a eukaryotic group II intron in the lariat-3′ exon form, immediately preceding the second step of splicing, analogous to the spliceosomal P complex. This structure reveals the location of the intact 3′ splice site within the catalytic core of the group II intron. The 3′-OH of the 5′ exon is positioned in close proximity to the 3′ splice site for nucleophilic attack and exon ligation. The active site undergoes conformational rearrangements with the catalytic triplex having different configurations before and after the second step of splicing. We describe a complete model for the second step of group II intron splicing that incorporates a dynamic catalytic triplex being responsible for creating the binding pocket for 3′ splice site capture.